Recce Pharmaceuticals (ASX:RCE) has extended the closing date of its share purchase plan (SPP) to Friday, providing eligible shareholders with additional time to subscribe for shares under the offer, according to a Monday Australian bourse filing.
The SPP allows shareholders to acquire up to AU$30,000 worth of fully paid ordinary shares at AU$0.40 per share, with no brokerage or transaction fees applicable, the filing said.
Participants will also have the opportunity to apply for free attaching options, subject to shareholder approval, which may include additional "piggyback" options upon exercise, the filing added.